AMPLA Pharmaceuticals Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for AMPLA Pharmaceuticals Inc..The latest application filed is for "treatment of metabolic syndrome with novel amides".
- AMPLA Pharmaceuticals Inc. - La Jolla CA
| Patent | Date |
|---|---|
| Treatment Of Metabolic Syndrome With Novel Amides App 20100292289 - Hauske; James R. | 2010-11-18 |
| Treatment Of Metabolic Syndrome With Lactams App 20090239909 - Hauske; James R. | 2009-09-24 |
| CB1 antagonists and inverse agonists App 20090036426 - Hauske; James R. | 2009-02-05 |
| Treatment of metabolic syndrome with norfluoxetine App 20080182898 - Hauske; James R. | 2008-07-31 |
| Treatment of metabolic syndrome with norfluoxetine App 20080140450 - Hauske; James R. | 2008-06-12 |
| CB1 antagonists and inverse agonists App 20080027087 - Bennett; Teresa A. ; et al. | 2008-01-31 |
| Potentiation of MC4 receptor activity App 20080027072 - Bennett; Teresa A. ; et al. | 2008-01-31 |
| SEC | 0001381508 | AMPLA PHARMACEUTICALS INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 